Aspirin use in essential thrombocythemia: Once-daily or twice-daily or not at all?

Published in: American journal of hematology (2024)

Asprin dosing strategy in low risk (young and JAK2 mutated without history of thrombosis) or very low risk (young JAK2 wild-type without history of thrombosis) essential thrombocythemia.

Keyphrases

wild type
pulmonary embolism
physical activity
middle aged
low dose
cardiovascular events
type diabetes
atrial fibrillation
acute coronary syndrome